Bipolar Disorder Management in a Perinatal Patient

November 12, 2025

Register For Zoom Link

To receive the link to the Zoom webinar, please register here.

 

Join The Periscope Project for our 2025 webinar series dedicated to building capacity to address mental health conditions in pregnant and postpartum patients. This series covers a wide range of topics related to perinatal mental health. The series is intended for health care providers/professionals interacting with people during any point in the perinatal period: pre-pregnancy through one year postpartum. Webinars take place via Zoom from 12pm-1pm CST. This webinar series is offered at no cost to participants.

The Periscope Project is a statewide provider-to-provider perinatal psychiatric access program. It offers three core services to build capacity in front-line health care providers to manage mental health conditions in pregnant, postpartum, and preconception patients:

  1. Provider to Perinatal Psychiatrist consultation within 30 minutes Monday – Friday 8 am to 4 pm.
  2. Linkages with community-based resources that support perinatal women’s mental health.
  3. Education and training for providers and staff on evidence-based treatment of perinatal psychiatric conditions.

Periscope can help OB/GYNs, midwives, family medicine, psychiatrists, and pediatricians by providing:

  1. Support with caring for perinatal patients with mental health needs.
  2. Health care providers with a treatment plan to bridge patients to psychiatric care.
  3. Education on perinatal mental health diagnosis and treatment.
  4. Reassurance on treatment of perinatal mental health disorders.
  5. Connections for patients to local mental health resources.

Target Audience

  • Physicians
  • Psychologists
  • Physician Assistants
  • Nurse Practitioners

Learning Objectives

Participants who engage in this educational intervention will be able to:

  • Identify risks of untreated bipolar disorder in pregnancy.
  • Describe link between postpartum psychosis and bipolar disorder discuss common treatments (e.g. lithium, valproic acid, carbamazepine, lamotrigine, class of atypical antipsychotics).
  • Describe risks to the fetus and newborn of exposure to mood stabilizers (e.g. lithium, valproic acid, carbamazepine, lamotrigine, class of atypical antipsychotics) in utero.
Additional information

Contact

Name: 
Caimen Masterson
Phone Number: 
+1 (414) 955-7250
Email: 
[email protected]
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
  • 0.75 NP Pharmacology
    NP Pharmacology credit.
  • 1.00 NP Contact Hours
Course opens: 
01/15/2025
Course expires: 
12/31/2025
Event starts: 
11/12/2025 - 12:00pm CST
Event ends: 
11/12/2025 - 1:00pm CST
Cost:
$0.00
Part of: 
The Periscope Project Perinatal Mental Health Series
Add to calendar: 
Virtual Meeting
United States
Zoom Registration

Activity Director:
Christina L. Wichman, DO
Professor of Psychiatry and Obstetrics and Gynecology
Vice Chair of Education, Department of Psychiatry and Behavioral Medicine
Medical Director, The Periscope Project
Co-Director, Women's Mental Health
Program Director, Consultation-Liaison Psychiatry Fellowship
Program Director, Northeastern Wisconsin Psychiatry Residency 
Medical College of Wisconsin

Planning Committee Members:
Jason Ipsarides, DNP, PMHNP-BC
Assistant Professor of Psychiatry 
Medical College of Wisconsin 

Speaker:
Christina L. Wichman, DO
Professor of Psychiatry and Obstetrics and Gynecology
Vice Chair of Education, Department of Psychiatry and Behavioral Medicine
Medical Director, The Periscope Project
Co-Director, Women's Mental Health
Program Director, Consultation-Liaison Psychiatry Fellowship
Program Director, Northeastern Wisconsin Psychiatry Residency 
Medical College of Wisconsin

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

  • Christina L. Wichman
  • Jason Ipsarides

ACCME ACCREDITATION STATEMENT
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
The Medical College of Wisconsin designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

HOURS OF PARTICIPATION FOR ALLIED HEALTH CARE PROFESSIONALS
The Medical College of Wisconsin designates this activity for up to 1 hour of participation for continuing education for allied health professionals.

Nurse Practitioner:
Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 150930.  This program has been approved for up to 1 contact hours of continuing education (which includes 0.75 hours of pharmacology).  Nurse Practitioners should claim only those hours actually spent participating in the CME activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
  • 0.75 NP Pharmacology
    NP Pharmacology credit.
  • 1.00 NP Contact Hours

Price

Cost:
$0.00
Please login or register to take this course.